M20 Genomics
PrivateLast Round
Early Funding
Jun 13, 2022
Momentum
Top 5%
of companies Caplight tracks
Company Overview
M20 Genomics operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was an Early Funding round in June 2022.
M20 Genomics is a life science technology company that develops and provides single-cell and spatial transcriptomics sequencing solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
M20 Genomics Comparables
Compare M20 Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing SeekGene BioSciences Co., Ltd. | 87% | |
| MobiDrop Biotech | 82% | |
| Singleron Biotechnologies | 79% |
For institutional investors. Book with your work email.
M20 Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 13, 2022 | ||||
| Early Funding | Apr 29, 2022 | ||||
| Angel | Dec 1, 2021 |
For institutional investors. Book with your work email.
M20 Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nest.Bio | Early Funding, Angel |
| Qiming Venture Partners | Early Funding, Angel |
| HongShan Capital Group (HSG) | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2026
Grew 38% QoQ, from 8 to 11 employees.
- Jul 16, 2026
Grew 43% QoQ, from 7 to 10 employees.
For institutional investors. Book with your work email.
M20 Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about M20 Genomics's valuation, stock price, and market status.
Is M20 Genomics a public or private company?
M20 Genomics is a private company.
What is the current stock price of M20 Genomics?
M20 Genomics is a private company, so its shares have no public market price. Caplight tracks M20 Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is M20 Genomics worth (valuation)?
Valuation information for M20 Genomics is not publicly available.
Can I buy M20 Genomics stock?
M20 Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was M20 Genomics's last funding round?
M20 Genomics's most recent funding round was Early Funding on June 13, 2022.
Who are the main investors in M20 Genomics?
Key investors in M20 Genomics include HongShan Capital Group (HSG).
Will M20 Genomics IPO soon?
No public IPO plans have been announced for M20 Genomics.
How can I track M20 Genomics secondary market activity?
Caplight tracks bids, offers, and trades in M20 Genomics's shares on secondary markets.